【英語タイトル】Global Organ Preservation Market Size Study and Forecast by Type (Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP), Normothermic Machine Perfusion (NMP), Others), Organ (Kidney, Liver, Heart, Lung, Others), Preservation Solution (Intracellular Solutions, Extracellular Solutions, Colloids, Others), End User (Hospitals, Organ Banks, Tissue Banks, Others), and Regional Forecasts 2026-2035

・商品コード：BZW0833HN772 ・発行会社（調査会社）：Research & Consulting ・発行日：2026年4月 ・ページ数：250 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル ・産業分野：医療・バイオ

Market Definition, Recent Developments and Industry Trends

The organ preservation market encompasses technologies, solutions, and systems designed to maintain the viability and functional integrity of donor organs from the point of retrieval until transplantation. Organ preservation methods are critical in extending the permissible time window between organ procurement and transplantation, thereby improving transplant success rates and enabling better logistical coordination. The market includes preservation solutions, perfusion systems, storage devices, and associated consumables used by hospitals, transplant centers, organ banks, and tissue banks. These solutions are primarily used in the preservation of kidneys, livers, hearts, lungs, and other transplantable tissues, playing a pivotal role in modern transplant medicine.
In recent years, the organ preservation landscape has evolved rapidly due to the increasing global burden of organ failure, rising demand for organ transplants, and technological advancements in perfusion systems. Traditional static cold storage methods continue to dominate due to their simplicity and cost efficiency; however, advanced machine perfusion technologies such as hypothermic and normothermic perfusion are gaining traction as they offer improved organ viability and functional assessment prior to transplantation. Additionally, the market is witnessing increased integration of precision medicine approaches, enhanced preservation solutions, and digital monitoring technologies. Regulatory support for organ donation programs and advancements in transplant infrastructure across emerging economies are expected to further shape market growth during the forecast period.

Key Findings of the Report
• Market Size (2024): USD 0.3 billion
• Estimated Market Size (2035): USD 0.64 billion
• CAGR (2026-2035): 7.20%
• Leading Regional Market: North America
• Leading Segment: Static Cold Storage (SCS)

Market Determinants

Rising Global Demand for Organ Transplantation

The growing incidence of chronic diseases such as kidney failure, liver cirrhosis, cardiovascular disorders, and pulmonary diseases has significantly increased the demand for organ transplantation worldwide. As transplant waiting lists continue to expand, healthcare systems are focusing on improving organ preservation techniques to maximize the usability of donated organs. Effective preservation directly influences transplant outcomes, making it a critical component in addressing the gap between organ supply and demand.

Advancements in Machine Perfusion Technologies

Technological innovations in hypothermic and normothermic machine perfusion systems are transforming the organ preservation landscape. These technologies enable continuous circulation of oxygenated preservation solutions through organs, maintaining metabolic activity and allowing clinicians to assess organ viability before transplantation. Such advancements are particularly beneficial for marginal or extended criteria donor organs, thereby expanding the donor pool and improving transplant success rates.

Expansion of Organ Donation Programs and Regulatory Support

Governments and healthcare organizations worldwide are increasingly promoting organ donation awareness programs and implementing supportive regulatory frameworks to improve organ procurement and transplantation rates. National transplant registries, donor allocation systems, and improved coordination among transplant centers are contributing to a more structured ecosystem, thereby supporting the demand for advanced preservation solutions and technologies.

High Cost and Infrastructure Requirements

Despite technological progress, the adoption of advanced machine perfusion technologies remains constrained by high equipment costs and the need for specialized infrastructure and trained personnel. Smaller hospitals and transplant centers, particularly in emerging economies, may face financial and operational barriers in adopting these systems, limiting widespread implementation.

Logistical Challenges in Organ Transportation

Organ transplantation relies heavily on precise timing and complex logistical coordination between donor hospitals, organ banks, and transplant centers. Limitations in transportation infrastructure, delays in retrieval or delivery, and geographical disparities can negatively impact organ viability. Consequently, the need for more robust preservation technologies capable of extending organ preservation time is becoming increasingly critical.

Opportunity Mapping Based on Market Trends

Adoption of Normothermic Machine Perfusion Systems

Improved Organ Viability and Assessment
Normothermic machine perfusion technologies replicate physiological conditions, enabling organs to function outside the body during transport. This approach allows clinicians to monitor metabolic activity and assess organ suitability prior to transplantation, significantly reducing the risk of post-transplant complications.

Expansion of Transplant Infrastructure in Emerging Economies

Growth in Healthcare Investment
Countries across Asia Pacific and parts of LAMEA are investing in advanced healthcare infrastructure, including specialized transplant centers and organ banks. As transplant programs expand in these regions, the demand for preservation solutions and perfusion technologies is expected to rise significantly.

Development of Next-Generation Preservation Solutions

Enhanced Biochemical Stability and Organ Protection
Pharmaceutical and biotechnology companies are actively developing advanced preservation solutions that improve cellular stability and minimize ischemic injury. These innovations are expected to extend preservation times and improve transplant outcomes, creating new revenue streams in the market.

Integration of Digital Monitoring and Remote Diagnostics

Data-Driven Organ Preservation
The integration of sensors, real-time monitoring, and digital platforms within perfusion systems is emerging as a promising trend. Such systems enable clinicians to monitor organ parameters during preservation and transportation, enhancing clinical decision-making and operational efficiency.

Key Market Segments

By Type
• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)
• Others

By Organ
• Kidney
• Liver
• Heart
• Lung
• Others

By Preservation Solution
• Intracellular Solutions
• Extracellular Solutions
• Colloids
• Others

By End User
• Hospitals
• Organ Banks
• Tissue Banks
• Others

Value-Creating Segments and Growth Pockets

Among preservation methods, Static Cold Storage (SCS) currently dominates the market due to its cost-effectiveness, simplicity, and widespread use in transplant procedures. It remains the standard approach for kidney and liver preservation in many healthcare settings. However, advanced machine perfusion technologies, particularly Normothermic Machine Perfusion (NMP), are expected to witness the fastest growth during the forecast period owing to their ability to improve organ viability and allow real-time functional assessment.
In terms of organ type, kidney preservation represents the largest market share due to the high prevalence of end-stage renal disease and the significant number of kidney transplant procedures performed globally. Meanwhile, liver and heart preservation technologies are anticipated to experience substantial growth as advanced perfusion systems enable longer preservation times and better clinical outcomes.
From the preservation solution perspective, intracellular and extracellular solutions collectively account for a significant share due to their established clinical use in organ storage. However, ongoing innovation in specialized biochemical formulations is expected to create new value pools. Hospitals currently represent the largest end-user segment due to the concentration of transplant surgeries, while organ banks are emerging as important growth drivers as centralized organ management systems become more prevalent.

Regional Market Assessment

North America
North America represents the leading regional market for organ preservation, supported by well-established transplant infrastructure, high awareness regarding organ donation, and strong regulatory frameworks. The region is also characterized by the early adoption of advanced machine perfusion technologies and significant investment in transplant research.

Europe
Europe holds a significant share of the global market due to strong healthcare systems, collaborative organ donation networks, and supportive policy frameworks. Regional initiatives aimed at increasing organ donation rates and optimizing cross-border organ sharing are expected to sustain demand for advanced preservation solutions.

Asia Pacific
Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rapid improvements in healthcare infrastructure, increasing prevalence of chronic diseases, and expanding transplant programs in countries such as China, India, and Japan are driving demand for organ preservation technologies.

LAMEA
The LAMEA region is gradually emerging as a promising market, supported by growing healthcare investments and increasing awareness regarding organ transplantation. Although the market remains at an early stage in several countries, ongoing improvements in transplant infrastructure and government initiatives are expected to create long-term growth opportunities.

Recent Developments
• January 2024: A leading medical technology company launched an advanced normothermic machine perfusion system designed to extend the preservation time of donor organs and improve transplant success rates, reflecting the growing shift toward functional organ preservation technologies.
• September 2023: A global healthcare technology firm announced a strategic collaboration with transplant centers to expand the adoption of hypothermic machine perfusion for kidney preservation, aimed at improving clinical outcomes for marginal donor organs.
• May 2023: A biotechnology company introduced an improved organ preservation solution formulated to reduce ischemic injury during cold storage, highlighting ongoing innovation in biochemical preservation technologies.

Critical Business Questions Addressed

What is the long-term value creation outlook for the global organ preservation market?
The report analyzes current market size, future growth projections, and structural demand drivers shaping market expansion through 2035.
Which technologies and preservation methods will drive the next phase of market growth?
The study evaluates the transition from traditional static cold storage toward advanced machine perfusion systems and their commercial implications.
Which market segments present the strongest investment opportunities?
Detailed segmentation analysis identifies high-growth areas across organ types, preservation technologies, and end-user categories.
How are regional dynamics influencing competitive strategies?
The report explores how regulatory frameworks, healthcare infrastructure, and transplant program maturity differ across regions and influence market development.
What strategic actions should industry stakeholders prioritize?
The analysis highlights opportunities for technology innovation, strategic partnerships, and expansion into emerging transplant markets.

Beyond the Forecast

The organ preservation market is evolving from a logistics-driven support function into a technologically sophisticated component of transplant medicine. As machine perfusion technologies mature, the ability to extend preservation windows and evaluate organ viability in real time will fundamentally reshape transplant workflows.
For industry participants, the next phase of competition will center on integrated preservation platforms that combine advanced perfusion systems, optimized preservation solutions, and digital monitoring capabilities. Organizations that successfully align innovation with expanding global transplant networks will be best positioned to capture long-term value in this specialized yet rapidly advancing market.